Empire Genomics
 | This article needs additional citations for verification. (November 2019) |
Empire Genomics is a cancer molecular diagnostics company. They make genetic tests for over 200 different types of health concerns.[1] It is based in Buffalo, New York in the United States.
Dr. Norma J. Nowak founded Empire Genomics in 2006 in Buffalo, New York.[2] It developed out of a project at Roswell Park Comprehensive Cancer Center.[3] Their headquarters is located in Buffalo at the Buffalo Niagara Medical Campus.[2]
The company develops non-invasive tests that focus around health concerns such as cancer, autism and Down syndrome.[3] In 2012, Empire Genomics released a test for multiple myeloma and opened a new laboratory to focus on the test. As of 2012, Anthony Johnson is chief executive officer.[2] That same year, the company received a $400,000 grant from the Empire State Development Corporation.[3]
On February 19, 2019, the company announced the appointments of Andy Watson as CEO and Anthony Scarpello to CCO, and the opening of its new headquarters in Williamsville, NY.
In November 2022, it was announced Empire Genomics had been acquired by the Pacheco-headquartered provider of automated immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) instrumentation and reagents, Biocare Medical.[4]
References[edit]
- ^ Bertola, Davis. "Empire Genomics building a new $1.2M lab". Buffalo Business First. Retrieved 27 December 2012.
- ^ a b c "Empire Genomics Creating 50 Jobs on Medical Campus". City. Buffalo Rising. Archived from the original on 18 January 2013. Retrieved 27 December 2012.
- ^ a b c Watson, Stephen. "Empire Genomics plans to expand". Business. The Buffalo News. Retrieved 27 December 2012.
- ^ "Biocare Medical Acquires Empire Genomics". NS Medical Devices. 2022-11-23. Retrieved 2022-11-23.
